March 20, 2026. More for You ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

Nearly one million Israelis live with chronic lung diseases such as asthma and COPD, and for them the current security ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Asthma and chronic obstructive pulmonary disease patients will receive better care closer to home under a landmark £10million partnership Care for ...

The National Health Fund (NHF) has expanded its NHFCard programme to include four additional chronic conditions and increased access to key diagnostic tests, in a move aimed at improving access to ...

Over 141,000 people are receiving financial support through Personal Independence Payment for over 20 respiratory conditions.

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has launched Aerolife ...

Zydus Lifesciences announced the launch of Aerolife Mini, a next-generation pressurised metered-dose inhaler (pMDI) enhancer, marking a key step in the company's strategy to drive drug-device-led ...

Millions of people living with lung conditions face heightened health risks this winter due to persistent wet weather and the ...